ArticleInternational journal of clinical practice2023

Serum Hsa_circ_0005962 Is A Prognostic Biomarker of Paclitaxel Resistance in Nonsmall Cell Lung Cancer Treatment.

Chenliang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.